NEW YORK, NY--(Marketwired - Jan 8, 2014) - Sticky, the only media technology company that has gone beyond viewability to absolute certainty on which ads are actually SEEN and not seen for branding campaign optimization, was selected as a top innovator of 2013 by PM360 -- the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech and medical device industries. Sticky was named "most innovative company" in PM360's special issue, Innovations in Pharma Marketing, alongside eleven other firms selected from hundreds of submissions.
PM360's annual call to innovation was open to organizations in operation for five years or less or underwent a strategic relaunch during that same period. Submissions were accepted in three categories: People, Products and Services. Innovators were selected among those making an impact on the industry and patients, while making the lives of brand marketers easier. Featured innovators offered a glimpse of people who are thinking differently and taking pharma to places it has never been before.
Jeff Bander, President of the New York City-based Sticky, said that the Sticky team is honored to be recognized as a top innovator of 2013.
"Sticky technology is revolutionizing the way that Rx brands measure engagement. We help our pharma clients optimize online branding campaigns for ads to actually be seen, not just the "potential to be seen" (aka viewability or in-screen). In turn, obtaining a greater return on ad spend by increasing the number of seen ads and time consumers see their brand for the same budget. No more guessing. No more 'praying and spraying.' Reallocate spend and budget to do more of what works, and stop wasting money on invisible ads."
Sticky technology was developed in 2009 in close partnership with Tobii Technology, the world leader in eye tracking and eye control. Sticky's patented global technology uses regular consumer webcams to track eye movement and identify which ads are seen and for how long -- making the process easy and less costly. Sticky's SEEN metric allows advertisers to track and analyze what matters: Which ads consumers spend time focusing on and paying actual attention to.
Sticky's pharma clients are seeing an average of a 25-65% increase in ads actually SEEN by consumers with no increase in budget.
For more information please visit www.sticky.ad or watch this video http://sticky.ad/meet-sticky-video/
Sticky is the only media technology company that has gone beyond viewability to absolute certainty on which ads are actually SEEN and not seen for branding campaign optimization. Sticky's disruptive technology provides brand advertisers with objective data to improve their digital performance, and can be used in conjunction with all their partners in the digital ecosystem to increase ROI. www.sticky.ad
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. www.pm360online.com